TY - JOUR
T1 - Association of time of day with outcomes among patients triaged for a suspected severe stroke in nonurban Catalonia
AU - RACECAT Trial Investigators
AU - García-Tornel, Álvaro
AU - Flores, Alan
AU - Terceño, Mikel
AU - Cardona, Pedro
AU - Amaro, Sergi
AU - Gomis, Meritxell
AU - Zaragoza, Josep
AU - Krupinski, Jerzy
AU - Gómez-Choco, Manuel
AU - Mas, Natalia
AU - Cocho, Dolores
AU - Catena, Esther
AU - Purroy, Francesc
AU - Deck, Matias
AU - Rubiera, Marta
AU - Pagola, Jorge
AU - Rodriguez-Luna, David
AU - Juega, Jesús
AU - Rodríguez-Villatoro, Noelia
AU - Molina, Carlos A.
AU - Soro, Cristina
AU - Jimenez, Xavier
AU - Salvat-Plana, Mercè
AU - Dávalos, Antoni
AU - Jovin, Tudor G.
AU - Abilleira, Sonia
AU - Pérez de la Ossa, Natalia
AU - Ribó, Marc
N1 - Publisher Copyright:
© 2023 Lippincott Williams and Wilkins. All rights reserved.
PY - 2023/3/1
Y1 - 2023/3/1
N2 - BACKGROUND: We aim to assess whether time of day modified the treatment effect in the RACECAT trial (Direct Transfer to an Endovascular Center Compared to Transfer to the Closest Stroke Center in Acute Stroke Patients With Suspected Large Vessel Occlusion Trial), a cluster-randomized trial that did not demonstrate the benefit of direct transportation to a thrombectomy-capable center versus nearest local stroke center for patients with a suspected large vessel stroke triaged in nonurban Catalonia between March 2017 and June 2020. METHODS: We performed a post hoc analysis of RACECAT to evaluate if the association between initial transport routing and functional outcome differed according to trial enrollment time: daytime (8:00 am-8:59 pm) and nighttime (9:00 pm-7:59 am). Primary outcome was disability at 90 days, as assessed by the shift analysis on the modified Rankin Scale score, in patients with ischemic stroke. Subgroup analyses according to stroke subtype were evaluated. RESULTS: We included 949 patients with an ischemic stroke, of whom 258 patients(27%) were enrolled during nighttime. Among patients enrolled during nighttime, direct transport to a thrombectomy-capable center was associated with lower degrees of disability at 90 days (adjusted common odds ratio [acOR], 1.620 [95% CI, 1.020-2.551]); no significant difference between trial groups was present during daytime (acOR, 0.890 [95% CI, 0.680-1.163]; Pinteraction=0.014). Influence of nighttime on the treatment effect was only evident in patients with large vessel occlusion(daytime, acOR 0.766 [95% CI, 0.548-1.072]; nighttime, acOR, 1.785 [95% CI, 1.024-3.112] ; Pinteraction<0.01); no heterogeneity was observed for other stroke subtypes (Pinteraction>0.1 for all comparisons). We observed longer delays in alteplase administration, interhospital transfers, and mechanical thrombectomy initiation during nighttime in patients allocated to local stroke centers. CONCLUSIONS: Among patients evaluated during nighttime for a suspected acute severe stroke in non-urban areas of Catalonia, direct transport to a thrombectomy-capable center was associated with lower degrees of disability at 90 days. This association was only evident in patients with confirmed large vessel occlusion on vascular imaging. Time delays in alteplase administration and interhospital transfers might mediate the observed differences in clinical outcome. REGISTRATION: URL: https://www. CLINICALTRIALS: gov; Unique identifier: NCT02795962.
AB - BACKGROUND: We aim to assess whether time of day modified the treatment effect in the RACECAT trial (Direct Transfer to an Endovascular Center Compared to Transfer to the Closest Stroke Center in Acute Stroke Patients With Suspected Large Vessel Occlusion Trial), a cluster-randomized trial that did not demonstrate the benefit of direct transportation to a thrombectomy-capable center versus nearest local stroke center for patients with a suspected large vessel stroke triaged in nonurban Catalonia between March 2017 and June 2020. METHODS: We performed a post hoc analysis of RACECAT to evaluate if the association between initial transport routing and functional outcome differed according to trial enrollment time: daytime (8:00 am-8:59 pm) and nighttime (9:00 pm-7:59 am). Primary outcome was disability at 90 days, as assessed by the shift analysis on the modified Rankin Scale score, in patients with ischemic stroke. Subgroup analyses according to stroke subtype were evaluated. RESULTS: We included 949 patients with an ischemic stroke, of whom 258 patients(27%) were enrolled during nighttime. Among patients enrolled during nighttime, direct transport to a thrombectomy-capable center was associated with lower degrees of disability at 90 days (adjusted common odds ratio [acOR], 1.620 [95% CI, 1.020-2.551]); no significant difference between trial groups was present during daytime (acOR, 0.890 [95% CI, 0.680-1.163]; Pinteraction=0.014). Influence of nighttime on the treatment effect was only evident in patients with large vessel occlusion(daytime, acOR 0.766 [95% CI, 0.548-1.072]; nighttime, acOR, 1.785 [95% CI, 1.024-3.112] ; Pinteraction<0.01); no heterogeneity was observed for other stroke subtypes (Pinteraction>0.1 for all comparisons). We observed longer delays in alteplase administration, interhospital transfers, and mechanical thrombectomy initiation during nighttime in patients allocated to local stroke centers. CONCLUSIONS: Among patients evaluated during nighttime for a suspected acute severe stroke in non-urban areas of Catalonia, direct transport to a thrombectomy-capable center was associated with lower degrees of disability at 90 days. This association was only evident in patients with confirmed large vessel occlusion on vascular imaging. Time delays in alteplase administration and interhospital transfers might mediate the observed differences in clinical outcome. REGISTRATION: URL: https://www. CLINICALTRIALS: gov; Unique identifier: NCT02795962.
KW - Catalonia (Spain)
KW - Emergency medical services
KW - Hospital
KW - Stroke
KW - Thrombectomy
KW - Spain
KW - Emergency medical services
KW - Hospital
KW - Stroke
KW - Thrombectomy
UR - http://www.scopus.com/inward/record.url?scp=85148975563&partnerID=8YFLogxK
UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000940824000037
U2 - 10.1161/STROKEAHA.122.041013
DO - 10.1161/STROKEAHA.122.041013
M3 - Article
C2 - 36848432
AN - SCOPUS:85148975563
SN - 0039-2499
VL - 54
SP - 770
EP - 780
JO - Stroke
JF - Stroke
IS - 3
ER -